ID: ALA5094658

Max Phase: Preclinical

Molecular Formula: C52H75N11O9

Molecular Weight: 998.24

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C

Standard InChI:  InChI=1S/C52H75N11O9/c1-30(2)25-40(47(68)59-39(45(53)66)27-34-15-10-8-11-16-34)62-51(72)44(32(5)6)63-50(71)41(26-31(3)4)60-49(70)43(29-36-20-22-37(65)23-21-36)61-46(67)38(19-14-24-56-52(54)55)58-48(69)42(57-33(7)64)28-35-17-12-9-13-18-35/h8-13,15-18,20-23,30-32,38-44,65H,14,19,24-29H2,1-7H3,(H2,53,66)(H,57,64)(H,58,69)(H,59,68)(H,60,70)(H,61,67)(H,62,72)(H,63,71)(H4,54,55,56)/t38-,39-,40-,41-,42-,43-,44-/m0/s1

Standard InChI Key:  WYTDWRNUHXAMTO-VLOLPVCOSA-N

Associated Targets(Human)

Leukocyte elastase 8173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 998.24Molecular Weight (Monoisotopic): 997.5749AlogP: 1.33#Rotatable Bonds: 29
Polar Surface Area: 328.92Molecular Species: BASEHBA: 10HBD: 12
#RO5 Violations: 2HBA (Lipinski): 20HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.50CX Basic pKa: 11.54CX LogP: 1.89CX LogD: 0.23
Aromatic Rings: 3Heavy Atoms: 72QED Weighted: 0.03Np Likeness Score: 0.09

References

1. Lior Y, Shtriker E, Kahremany S, Lewis EC, Gruzman A..  (2022)  Development of anti-inflammatory peptidomimetics based on the structure of human alpha1-antitrypsin.,  228  [PMID:34763945] [10.1016/j.ejmech.2021.113969]

Source